STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company

Adaptive Biotechnologies Corp

Filed

March 13, 2026

Period of Report

March 11, 2026

Accession Number

0001820885-26-000004